Bernard Lespérance
Hôpital du Sacré-Cœur de Montréal(CA)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, BRCA gene mutations in cancer, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Genetic factors in colorectal cancer
Most-Cited Works
- → Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial(2019)549 cited
- → HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel(2004)138 cited
- → Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel(2004)93 cited
- → Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families(2006)61 cited
- → No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families(2006)52 cited
- → Recommendations on Breast Cancer Screening and Prevention in the Context of Implementing Risk Stratification: Impending Changes to Current Policies(2016)44 cited
- → Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine(2013)42 cited
- → Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer(2004)35 cited
- → Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study(1999)35 cited
- → Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families(2007)30 cited